Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression
- DOI
- 10.1016/j.celrep.2025.115673
- Published
- 2025-05
- Container
- Cell Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.celrep.2025.115673,
title = {Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression},
author = {Wanchen Wang and Kohei Kumegawa and Owen S. Chapman and Ryo Shiraishi and Zhize Xiao and Konstantin Okonechnikov and Yang Sun and Stefan M. Pfister and Weijun Feng and Naofumi Uesaka and Mikio Hoshino and Satoru Takahashi and Andrey Korshunov and Lukas Chavez and Reo Maruyama and Daisuke Kawauchi},
year = {2025},
journal = {Cell Reports},
doi = {10.1016/j.celrep.2025.115673},
url = {https://doi.org/10.1016/j.celrep.2025.115673}
}RIS
TY - JOUR TI - Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression AU - Wanchen Wang AU - Kohei Kumegawa AU - Owen S. Chapman AU - Ryo Shiraishi AU - Zhize Xiao AU - Konstantin Okonechnikov AU - Yang Sun AU - Stefan M. Pfister AU - Weijun Feng AU - Naofumi Uesaka AU - Mikio Hoshino AU - Satoru Takahashi AU - Andrey Korshunov AU - Lukas Chavez AU - Reo Maruyama AU - Daisuke Kawauchi PY - 2025 JO - Cell Reports DO - 10.1016/j.celrep.2025.115673 UR - https://doi.org/10.1016/j.celrep.2025.115673 ER -
APA
Wang, W., Kumegawa, K., Chapman, O. S., Shiraishi, R., Xiao, Z., Okonechnikov, K., Sun, Y., Pfister, S. M., Feng, W., Uesaka, N., Hoshino, M., Takahashi, S., Korshunov, A., Chavez, L., Maruyama, R., & Kawauchi, D. (2025). Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115673
Source records
- crossref · retrieved 2026-09-24T17:01:08.033Z